Inventor · disambiguated record
Jeffrey C. Johnson
Also filed as: JOHNSON JEFFREY · JOHNSON JEFFREY C
6 granted patents·9 pending applications·46 citations·filing 2001–2023
79Inventor score
Top patents by PatentIndex Score
15 records- 0189US6858204B2Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2001·Granted Feb 22, 2005·35 cites·6 claims
- 0286US7425607B2Compositions comprising a lung tumor antigenCORIXA CORP·Filed 2005·Granted Sep 16, 2008·8 cites·4 claims
- 0383US9732367B2Cell linesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·3 cites·6 claims
- 0465US2024075133A1Methods and compositions for reduction of immunogenicityCELGENE CORP·Filed 2023·Application pending·0 cites
- 0563US10253345B2Cell linesMEDIMMUNE LTD·Filed 2017·Granted Apr 9, 2019·0 cites·13 claims
- 0659US12428488B2Engineering of an antibody for tumor-selective binding of CD47CELGENE CORP·Filed 2020·Granted Sep 30, 2025·0 cites·17 claims
- 0758US2008292633A1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2007·Application pending·0 cites
- 0858US2008171048A1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2007·Application pending·0 cites
- 0958US2008171690A1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2007·Application pending·0 cites
- 1053US2020330590A1Methods and compositions for reduction of immunogenicityCELGENE CORP·Filed 2018·Application pending·0 cites
- 1152US2023365681A1Bispecific antibody treatment of lymphoid malignant neoplasm conditionsCELGENE CORP·Filed 2021·Application pending·0 cites
- 1250US2003211510A1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2002·Application pending·0 cites
- 1346US2002172952A1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2001·Application pending·0 cites
- 1441US2003045468A1Compositions and methods for the therapy, diagnosis and monitoring of breast cancerCORIXA CORP·Filed 2002·Application pending·0 cites
- 1537US11427632B2Antibodies with low immunogenicity and uses thereofCELGENE CORP·Filed 2017·Granted Aug 30, 2022·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey C. Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →